for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Reuters Now

Valeant shares step up with CEO stepping down

Posted

The CEO of embattled drug company Valeant is leaving and hedge fund investor Bill Ackman is joining the board amid heightened scrutiny and a 90 percent drop in the stock price since August.

Reuters Now

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up